The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor

Genes and Development

Volumn 22, Issue 7, 2008, Pages 884-893

  Schlisio, Susanne ^a   Kenchappa, Rajappa S ^b   Vredeveld, Liesbeth C W ^c   George, Rani E ^a   Stewart, Rodney ^a   Greulich, Heidi ^a,d   Shahriari, Kristina ^a   Nguyen, Nguyen V ^e   Pigny, Pascal ^f   Dahia, Patricia L ^e   Pomeroy, Scott L ^a   Maris, John M ^g   Look, A Thomas ^a   Meyerson, Matthew ^a   Peeper, Daniel S ^c   Carter, Bruce D ^b   Kaelin Jr , William G ^a,h  

^a HARVARD MEDICAL SCHOOL   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Apoptosis; Kinesin; Neuroblastoma; Pheochromocytoma; Prolyl hydroxylase

Indexed keywords

KINESIN; NERVE GROWTH FACTOR; PROTEIN 1P36; PROTEIN EGLN3; PROTEIN KIF1B BETA; PROTEIN NF 1; PROTEIN RET; PROTEIN SUBUNIT; SHORT HAIRPIN RNA; SUCCINATE DEHYDROGENASE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN; DNA BINDING PROTEIN; EGLN1 PROTEIN, MOUSE; IMMEDIATE EARLY PROTEIN; KIF1B PROTEIN, MOUSE; NERVE PROTEIN;

APOPTOSIS; ARTICLE; CHROMOSOME 1P; CONTROLLED STUDY; DOWN REGULATION; FAMILIAL CANCER; GENE DELETION; GENE MUTATION; HUMAN; HUMAN CELL; MEDULLOBLASTOMA; MISSENSE MUTATION; MOLECULAR DYNAMICS; NEURAL CREST CELL; NEUROBLASTOMA; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTEIN FUNCTION; STEM CELL; TUMOR SUPPRESSOR GENE; ANIMAL; BIOLOGICAL MODEL; CELL CULTURE; CELL STRAIN; CHILD; CHROMOSOME; CHROMOSOME MAP; CYTOLOGY; GENETICS; HELA CELL; IMMUNOBLOTTING; METABOLISM; MOUSE; MOUSE MUTANT; NERVE CELL; NEWBORN; PATHOLOGY; RAT; RNA INTERFERENCE;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELLS, CULTURED; CHILD; CHROMOSOME MAPPING; CHROMOSOMES, MAMMALIAN; DNA-BINDING PROTEINS; HELA CELLS; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOBLOTTING; KINESIN; MEDULLOBLASTOMA; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; MUTATION, MISSENSE; NERVE TISSUE PROTEINS; NEUROBLASTOMA; NEURONS; PC12 CELLS; PHEOCHROMOCYTOMA; RATS; RNA INTERFERENCE; TUMOR SUPPRESSOR PROTEINS;

EID: 41649116940     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.1648608     Document Type: Article

References (49)

1. Aloyz, R.S., Bamji, S.X., Pozniak, C.D., Toma, J.G., Atwal, J., Kaplan, D.R., and Miller, F.D. 1998. p53 is essential for developmental neuron death as regulated by the TrkA and p75 neurotrophin receptors. J. Cell Biol. 143: 1691-1703.
2. Bagchi, A., Papazoglu, C., Wu, Y., Capurso, D., Brodt, M., Francis, D., Bredel, M., Vogel, H., and Mills, A.A. 2007. CHD5 is a tumor suppressor at human 1p36. Cell 128: 459-475.
3. Benn, D.E., Dwight, T., Richardson, A.L., Delbridge, L., Bambach, C.P., Stowasser, M., Gordon, R.D., Marsh, D.J., and Robinson, B.G. 2000. Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p. Cancer Res. 60: 7048-7051.
4. Berns, K., Hijmans, E.M., Mullenders, J., Brummelkamp, T.R., Velds, A., Heimerikx, M., Kerkhoven, R.M., Madiredjo, M., Nijkamp, W., Weigelt, B., et al. 2004. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428: 431-437.
5. Berra, E., Benizri, E., Ginouves, A., Volmat, V., Roux, D., and Pouyssegur, J. 2003. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia. EMBO J. 22: 4082-4090.
6. Brodeur, G.M. 1994. Molecular pathology of human neuroblastomas. Semin. Diagn. Pathol. 11: 118-125.
7. Brodeur, G.M., Sekhon, G., and Goldstein, M.N. 1977. Chromosomal aberrations in human neuroblastomas. Cancer 40: 2256-2263.
8. Brodeur, G.M., Pritchard, J., Berthold, F., Carlsen, N.L., Castel, V., Castelberry, R.P., De Bernardi, B., Evans, A.E., Favrot, M., Hedborg, F., et al. 1993. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J. Clin. Oncol. 11: 1466-1477.
9. Brummelkamp, T.R., Bernards, R., and Agami, R. 2002a. A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550-553.
10. Brummelkamp, T.R., Bernards, R., and Agami, R. 2002b. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2: 243-247.
11. Caren, H., Ejeskar, K., Fransson, S., Hesson, L., Latif, F., Sjoberg, R.M., Krona, C., and Martinsson, T. 2005. A cluster of genes located in 1p36 are down-regulated in neuroblastomas with poor prognosis, but not due to CpG island methylation. Mol. Cancer 4: 10. doi: 10.1186/1476-4598-4-10.
12. Cheng, N.C., Van Roy, N., Chan, A., Beitsma, M., Westerveld, A., Speleman, F., and Versteeg, R. 1995. Deletion mapping in neuroblastoma cell lines suggest two distinct tumor suppressor genes in the 1p36 region, only one of which is associated with N-myc amplification. Oncogene 10: 291-297.
13. Fairchild, R., Kyner, J., Hermreck, A., and Schimke, R. 1979. Neuroblastoma, pheochromocytoma, and renal cell carcinoma. Occurrence in a single patient. JAMA 242: 2210-2211.
14. George, R.E., Attiyeh, E.F., Li, S., Moreau, L.A., Neuberg, D., Li, C., Fox, E.A., Meyerson, M., Diller, L., Fortina, P., et al. 2007. Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays. PLoS ONE 2: e255. doi: 10.1371/journal.pone.0000255.
15. Haag, M.M., Soukup, S.W., and Neely, J.E. 1981. Chromosome analysis of a human neuroblastoma. Cancer Res. 41: 2995-2999.
16. Ichimiya, S., Nimura, Y., Kageyama, H., Takada, N., Sunahara, M., Shishikura, T., Nakamura, Y., Sakiyama, S., Seki, N., Ohira, M., et al. 1999. p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent. Oncogene 18: 1061-1066.
17. Johnson, M.R., Look, A.T., DeClue, J.E., Valentine, M.B., and Lowy, D.R. 1993. Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP.Ras. Proc. Natl. Acad. Sci. 90: 5539-5543.
18. Kenchappa, R.S., Zampieri, N., Chao, M.V., Barker, P.A., Teng, H.K., Hempstead, B.L., and Carter, B.D. 2006. Ligand-dependent cleavage of the P75 neurotrophin receptor is necessary for NRIF nuclear translocation and apoptosis in sympathetic neurons. Neuron 50: 219-232.
19. Kimmel, C.B., Ballard, W.W., Kimmel, S.R., Ullmann, B., and Schilling, T.F. 1995. Stages of embryonic development of the zebrafish. Dev. Dyn. 203: 253-310.
20. Knudson Jr., A.G. and Meadows, A.T. 1976. Developmental genetics of neuroblastoma. J. Natl. Cancer Inst. 57: 675-682.
21. Knudson Jr., A.G. and Strong, L.C. 1972. Mutation and cancer: Neuroblastoma and pheochromocytoma. Am. J. Hum. Genet. 24: 514-532.
22. Krona, C., Ejeskar, K., Abel, F., Kogner, P., Bjelke, J., Bjork, E., Sjoberg, R.M., and Martinsson, T. 2003. Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2. Oncogene 22: 2343-2351.
23. Lee, M., Draoui, M., Zia, F., Gazdar, A., Oie, H., Bepler, G., Bellot, F., Tarr, C., Kris, R., and Moody, T. 1992. Epidermal growth factor receptor monoclonal antibodies inhibit the growth of lung cancer cell line. J. Natl. Cancer Inst. Monogr. 13: 117-123.
24. Lee, S., Nakamura, E., Yang, H., Wei, W., Linggi, M.S., Sajan, M.P., Farese, R.V., Freeman, R.S., Carter, B.D., Kaelin Jr., W.G., et al. 2005. Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer. Cancer Cell 8: 155-167.
25. Lipscomb, E., Sarmiere, P., Crowder, R., and Freeman, R. 1999. Expression of the SM-20 gene promotes death in nerve growth factor-dependent sympathetic neurons. J. Neurochem. 73: 429-432.
26. Maris, J.M. 2005. The biologic basis for neuroblastoma heterogeneity and risk stratification. Curr. Opin. Pediatr. 17: 7-13.
27. Nagai, M., Ichimiya, S., Ozaki, T., Seki, N., Mihara, M., Furuta, S., Ohira, M., Tomioka, N., Nomura, N., Sakiyama, S., et al. 2000. Identification of the full-length KIAA0591 gene encoding a novel kinesin-related protein which is mapped to the neuroblastoma suppressor gene locus at 1p36.2. Int. J. Oncol. 16: 907-916.
28. Nakamura, E. and Kaelin Jr., W.G. 2006. Recent insights into the molecular pathogenesis of pheochromocytoma and paraganglioma. Endocr. Pathol. 17: 97-106.
29. Nangaku, M., Sato-Yoshitake, R., Okada, Y., Noda, Y., Takemura, R., Yamazaki, H., and Hirokawa, N. 1994. KIF1B, a novel microtubule plus end-directed monomeric motor protein for transport of mitochondria. Cell 79: 1209-1220.
30. Nickerson, D.A., Tobe, V.O., and Taylor, S.L. 1997. PolyPhred: Automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res. 25: 2745-2751.
31. Ohira, M., Kageyama, H., Mihara, M., Furuta, S., Machida, T., Shishikura, T., Takayasu, H., Islam, A., Nakamura, Y., Takahashi, M., et al. 2000. Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line. Oncogene 19: 4302-4307.
32. Opocher, G., Schiavi, F., Vettori, A., Pampinella, F., Vitiello, L., Calderan, A., Vianello, B., Murgia, A., Martella, M., Taccaliti, A., et al. 2003. Fine analysis of the short arm of chromosome 1 in sporadic and familial pheochromocytoma. Clin. Endocrinol. (Oxf.) 59: 707-715.
33. Palmada, M., Kanwal, S., Rutkoski, N.J., Gustafson-Brown, C., Johnson, R.S., Wisdom, R., and Carter, B.D. 2002. c-jun is essential for sympathetic neuronal death induced by NGF withdrawal but not by p75 activation. J. Cell Biol. 158: 453-461.
34. Peeper, D.S., Shvarts, A., Brummelkamp, T., Douma, S., Koh, E.Y., Daley, G.Q., and Bernards, R. 2002. A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence. Nat. Cell Biol. 4: 148-153.
35. Schwab, M., Praml, C., and Amler, L.C. 1996. Genomic instability in 1p and human malignancies. Genes Chromosomes Cancer 16: 211-229.
36. Shimada, H., Chatten, J., Newton Jr., W.A., Sachs, N., Hamoudi, A.B., Chiba, T., Marsden, H.B., and Misugi, K. 1984. Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J. Natl. Cancer Inst. 73: 405-416.
37. Sommer, L. and Rao, M. 2002. Neural stem cells and regulation of cell number. Prog. Neurobiol. 66: 1-18.
38. Stoler, A. and Bouck, N. 1985. Identification of a single chromosome in the normal human genome essential for suppression of hamster cell transformation. Proc. Natl. Acad. Sci. 82: 570-574.
39. Straub, J.A., Lipscomb, E.A., Yoshida, E.S., and Freeman, R.S. 2003. Induction of SM-20 in PC12 cells leads to increased cytochrome c levels, accumulation of cytochrome c in the cytosol, and caspase-dependent cell death. J. Neurochem. 85:318-328.
40. Takeda, O., Homma, C., Maseki, N., Sakurai, M., Kanda, N., Schwab, M., Nakamura, Y., and Kaneko, Y. 1994. There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma. Genes Chrom. and Cancer 10: 30-39.
41. Tatekawa, Y., Muraji, T., Nishijima, E., Yoshida, M., and Tsugawa, C. 2006. Composite pheochromocytoma associated with adrenal neuroblastoma in an infant: A case report. J. Pediatr. Surg. 41: 443-445.
42. The, I., Murthy, A.E., Hannigan, G.E., Jacoby, L.B., Menon, A.G., Gusella, J.F., and Bernards, A. 1993. Neurofibromatosis type 1 gene mutations in neuroblastoma. Nat. Genet. 3: 62-66.
43. Thorisson, G.A., Smith, A.V., Krishnan, L., and Stein, L.D. 2005. The International HapMap Project Web site. Genome Res. 15: 1592-1593.
44. Wang, Q., Diskin, S., Rappaport, E., Attiyeh, E., Mosse, Y., Shue, D., Seiser, E., Jagannathan, J., Shusterman, S., Bansal, M., et al. 2006. Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. Cancer Res. 66: 6050-6062.
45. Westerfield, M. 1993. The zebrafish book. University of Oregon Press, Eugene, OR.
46. White, P.S., Thompson, P.M., Gotoh, T., Okawa, E.R., Igarashi, J., Kok, M., Winter, C., Gregory, S.G., Hogarty, M.D., Maris, J.M., et al. 2005. Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma. Oncogene 24: 2684-2694.
47. Yang, H.W., Chen, Y.Z., Takita, J., Soeda, E., Piao, H.Y., and Hayashi, Y. 2001. Genomic structure and mutational analysis of the human KIF1B gene which is homozygously deleted in neuroblastoma at chromosome 1p36.2. Oncogene 20: 5075-5083.
48. Zhao, C., Takita, J., Tanaka, Y., Setou, M., Nakagawa, T., Takeda, S., Yang, H.W., Terada, S., Nakata, T., Takei, Y., et al. 2001. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1B. Cell 105: 587-597.
49. Zhu, Y. and Parada, L.F. 2002. The molecular and genetic basis of neurological tumours. Nat. Rev. Cancer 2: 616-626.